Feedback / Questions
recombinant human plasma gelsolin (rhu-pGSN) - BioAegis Therap
https://www.globenewswire.com/news-release/2025/06/17/3101007/0/en/BioAegis-Therapeutics-Receives-FDA-Fast-Track-Designation-for-Lead-Product-Recombinant-Human-Gelsolin-for-the-Treatment-of-Acute-Respiratory-Distress-Syndrome-ARDS.html
Jun 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next